Alcon (ALC) Gains from Investment Securities (2009 - 2026)
Alcon (ALC) posted quarterly Gains from Investment Securities of $2.0 million for Q1 2026, down 77.78% on a QoQ basis from $9.0 million in Q4 2025.
Alcon (ALC) Gains from Investment Securities (2009 - 2026) Analysis & Trends
Alcon (ALC) has reported Gains from Investment Securities for 11 consecutive years, with $2.0 million the latest figure, recorded in Q1 2026.
- Quarterly Gains from Investment Securities changed N/A year-over-year to $2.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $17.0 million (changed N/A YoY) and the FY2025 annual result came in at $16.0 million, changed 0.0% from the prior year.
- Gains from Investment Securities fell to $2.0 million in Q1 2026 per ALC's latest filing, from $9.0 million in the prior quarter.
- Over the last five years, Gains from Investment Securities for ALC reached as high as $10.0 million in Q2 2023 and fell as low as $1.0 million in Q1 2022.
- A 5-year average of $4.4 million and a median of $3.5 million in 2023 frame the typical range for Gains from Investment Securities.
- Annual changes were most pronounced in 2023 — Gains from Investment Securities soared 900.0% — and 2024, when it tumbled 90.0%.
- Year by year, Gains from Investment Securities stood at $7.0 million in 2022, then declined by 14.29% to $6.0 million in 2023, then tumbled by 50.0% to $3.0 million in 2024, then surged by 200.0% to $9.0 million in 2025, then plunged by 77.78% to $2.0 million in 2026.
- According to Business Quant data, Gains from Investment Securities over the past three periods registered $2.0 million, $9.0 million, and $5.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn |
| 10 | Baxter International | 12.00 Bn | 9.98 Bn | 891.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.00 Mn |
| Mar 31, 2026 | 2.00 Mn |
| Dec 31, 2025 | 9.00 Mn |
| Dec 31, 2025 | 9.00 Mn |
| Sep 30, 2025 | 5.00 Mn |
| Sep 30, 2025 | 5.00 Mn |
| Jun 30, 2025 | 1.00 Mn |
| Jun 30, 2025 | 1.00 Mn |
| Dec 31, 2024 | 3.00 Mn |
| Dec 31, 2024 | 3.00 Mn |
| Sep 30, 2024 | 10.00 Mn |
| Sep 30, 2024 | 10.00 Mn |
| Jun 30, 2024 | 1.00 Mn |
| Jun 30, 2024 | 1.00 Mn |
| Mar 31, 2024 | 2.00 Mn |
| Mar 31, 2024 | 2.00 Mn |
| Dec 31, 2023 | 6.00 Mn |
| Dec 31, 2023 | 6.00 Mn |
| Sep 30, 2023 | 7.00 Mn |
| Sep 30, 2023 | 7.00 Mn |